Paper Details

  1. Home
  2. Paper Details

Ophthalmic adverse effects of BRAF inhibitors.

Author: Castillejo BecerraClara M, DalvinLauren A, SmithWendy M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

BRAF inhibitors are used for systemic malignancies, but they can cause ophthalmic side effects. This retrospective study found that 1.6% of patients experienced ophthalmic side effects, most commonly uveitis and dry eye. These events were generally resolved with local ophthalmic therapy, highlighting the importance of monitoring for ophthalmic side effects during BRAF inhibitor therapy.
Paper Details　
Original Abstract of the Article :
To determine the frequency, characteristics, and clinical course of ophthalmic side effects associated with systemic BRAF inhibitor therapy. Medical records of patients taking BRAF inhibitors for the treatment of systemic malignances at Mayo Clinic, Rochester from 01/01/2010 to 08/30/2021, were retr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/11206721221132872

データ提供：米国国立医学図書館（NLM）

Ophthalmic Adverse Effects of BRAF Inhibitors

Imagine a camel caravan crossing a vast desert, encountering unexpected challenges. This research explores the potential ophthalmic side effects of BRAF inhibitors, a class of drugs used to treat certain cancers. It examines the frequency, characteristics, and clinical course of these side effects, similar to a caravan leader carefully assessing the potential risks and challenges of the journey. This research provides valuable insights into the safety and management of BRAF inhibitor therapy.

Understanding the Side Effects of BRAF Inhibitors

This study finds that ophthalmic side effects associated with BRAF inhibitor therapy are relatively rare but can occur. The most common side effect is uveitis, an inflammation of the eye's middle layer. This research is like a caravan leader encountering a sudden sandstorm, requiring adjustments to the journey to minimize its impact. This research provides important information for doctors and healthcare providers in managing potential side effects of BRAF inhibitor therapy.

Navigating the Landscape of Cancer Treatment: Insights for Patient Care

This research highlights the importance of monitoring for potential ophthalmic side effects in patients receiving BRAF inhibitor therapy. It emphasizes the need for early detection and management of these side effects to minimize their impact on vision and overall health. This study, like a caravan navigating a challenging terrain, provides valuable guidance for ensuring safe and effective cancer treatment.

Dr. Camel's Conclusion

This study explores the potential ophthalmic side effects of BRAF inhibitors, a class of drugs used to treat cancer. Just like a camel caravan encountering unexpected sandstorms, this research highlights the importance of careful monitoring and management of potential side effects to ensure the safety and effectiveness of cancer treatment.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-10-11
Further Info :

Pubmed ID

36217756

DOI: Digital Object Identifier

10.1177/11206721221132872

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.